Related Experiment Video
Updated: Jun 19, 2026

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
Altered hippocampal morphology in unmedicated patients with major depressive illness
Carrie E Bearden1, Paul M Thompson, Christina Avedissian
1Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, CA 90095, USA. cbearden@mednet.ucla.edu
Abstract:
Despite converging evidence that major depressive illness is associated with both memory impairment and hippocampal pathology, findings vary widely across studies and it is not known whether these changes are regionally specific. In the present study we acquired brain MRIs (magnetic resonance images) from 31 unmedicated patients with MDD (major depressive disorder; mean age 39.2+/-11.9 years; 77% female) and 31 demographically comparable controls. Three-dimensional parametric mesh models were created to examine localized alterations of hippocampal morphology. Although global volumes did not differ between groups, statistical mapping results revealed that in MDD patients, more severe depressive symptoms were associated with greater left hippocampal atrophy, particularly in CA1 (cornu ammonis 1) subfields and the subiculum. However, previous treatment with atypical antipsychotics was associated with a trend towards larger left hippocampal volume. Our findings suggest effects of illness severity on hippocampal size, as well as a possible effect of past history of atypical antipsychotic treatment, which may reflect prolonged neuroprotective effects. This possibility awaits confirmation in longitudinal studies.
Insights
Major depressive disorder is linked to left hippocampal atrophy, especially in severe cases. Past antipsychotic treatment may offer neuroprotection, potentially increasing hippocampal volume.
Area of Science:
- Neuroscience
- Psychiatry
- Radiology
Background:
- Major depressive disorder (MDD) is associated with memory deficits and hippocampal changes.
- Previous research shows varied findings on the specificity of these hippocampal alterations.
Purpose of the Study:
- To investigate regionally specific hippocampal morphology changes in unmedicated patients with MDD.
- To explore the relationship between depressive symptom severity and hippocampal atrophy.
- To examine the potential influence of prior atypical antipsychotic treatment on hippocampal volume.
Main Methods:
- Acquired brain MRIs from 31 unmedicated MDD patients and 31 controls.
- Utilized 3D parametric mesh models for localized hippocampal morphology analysis.
- Performed statistical mapping to identify significant alterations.
Main Results:
- No significant global hippocampal volume differences were found between groups.
- Increased depressive symptom severity correlated with greater left hippocampal atrophy, particularly in CA1 and subiculum subfields.
- A trend suggested larger left hippocampal volume in patients with prior atypical antipsychotic treatment.
Conclusions:
- Illness severity in MDD impacts specific left hippocampal subfields.
- Past treatment with atypical antipsychotics may have neuroprotective effects on hippocampal volume.
- Longitudinal studies are needed to confirm the neuroprotective effects of antipsychotic treatment.
Related Concept Videos
Role of Hippocampus in Memory
Depression: Overview
Alzheimer Disease ll: Pathophysiology
Long-term Depression
Calcium Ion Concentration Mechanism
If over time, all...

